Inventor · disambiguated record
Steven Elliot Kauder
Also filed as: KAUDER STEVEN · KAUDER STEVEN E · KAUDER STEVEN ELLIOT
10 granted patents·2 pending applications·75 citations·filing 2011–2023
88Inventor score
Top patents by PatentIndex Score
12 records- 0197US11208459B2Constructs having a SIRP-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2020·Granted Dec 28, 2021·8 cites·54 claims
- 0296US10696730B2Constructs having a SIRP-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2018·Granted Jun 30, 2020·11 cites·54 claims
- 0396US10259859B2Constructs having a SIRP-α domain or variant thereofALX ONCOLOGY INC·Filed 2016·Granted Apr 16, 2019·35 cites·137 claims
- 0494US11242404B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2021·Granted Feb 8, 2022·3 cites·30 claims
- 0593US11639376B2Constructs having a SIRP-α domain or variant thereofALX ONCOLOGY INC·Filed 2020·Granted May 2, 2023·3 cites·28 claims
- 0692US9763922B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2015·Granted Sep 19, 2017·9 cites·20 claims
- 0791US11401338B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2017·Granted Aug 2, 2022·6 cites·37 claims
- 0885US2024343778A1Constructs having a sirp-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 0975US12404340B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2021·Granted Sep 2, 2025·0 cites·37 claims
- 1055US2017333406A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 1146US9474788B2Methods for the reactivation of latent HIV using cytosine methylation inhibitors and NF-KB activatorsVERDIN ERIC M·Filed 2011·Granted Oct 25, 2016·0 cites·7 claims
- 1239US10005848B2Method of reducing blood glucose by administering RON agonistsGENENTECH INC·Filed 2015·Granted Jun 26, 2018·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Steven Elliot Kauder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →